Advanced search×

Newborn screening for MCAD deficiency: experience of the first three years in British Columbia, Canada.

Can J Public Health 99(4):276-80 (2008) PMID 18767270

Medium Chain Acyl-CoA Dehydrogenase (MCAD) Deficiency is an autosomal recessive disorder of fatty acid oxidation, with potential fatal outcome. MCAD deficiency is diagnosed by acylcarnitine analysis on newborn screening blood spot cards by tandem mass spectrometry. Early diagnosis of MCAD and presymptomatic treatment can potentially reduce morbidity and mortality.

Version: za2963e q8zaa q8zbc q8zcb q8zd0 q8zef q8zf2 q8zg5

Similar articles you may find interesting…

  1. The structure of paranoia in the general population.

    Br J Psychiatry (2013) PMID 23661767

    The paranoia continuum has implications for the aetiology, mechanisms and treatment of psychotic disorders, while confirming the lack of a clear distinction from normal experiences and processes....
  2. The Development and Evaluation of Triage Algorithms for Early Discovery of Adverse Drug Interactions.

    Drug Saf (2013) PMID 23640657

    A range of predictors for adverse drug interaction signals have been identified. They substantially improve signal detection capacity compared with disproportionality analysis alone. The value of incorporating clinical and pharmacological information in first-pass screening is clear....
  3. RETINAL INNER NUCLEAR LAYER MICROCYSTIC CHANGES IN OPTIC NERVE ATROPHY: A Novel Spectral-Domain OCT Finding.

    Retina (2013) PMID 23644558

    : A total of 36 eyes were included in the study. Patients' mean age was 37 years. The major cause of optic atrophy was glaucoma (12 cases). The retinal pseudocysts were observed as hyporeflective lesions in the internal nuclear layer. Infrared images revealed a hyporeflective circular or semilunar sh...